EAN News

Our paper of the month for April is the latest work by the Global Burden of Diseases Collaborator Network, which has found that neurological conditions are the leading cause of ill health and disability worldwide, with over 3.4 billion people worldwide are affected.

The 2024 European Brain Health Summit focuses on a holistic approach to brain health, addressing the management of neurological disorders, preventive strategies, and public awareness. Watch the live broadcast on 7 May on the EAN Website.

A Joint Session between the EPA and EAN will take place during the European Congress of Psychiatry, on Monday, 8 April.

We are delighted to announce the three winners of our EAN 2024 Congress Quiz, each of whom has won free registration for the 10th Congress of the European Academy of Neurology in Helsinki!

EAN President-Elect, Elena Moro shares her plan for the future of neurology and highlights current key events and activities.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for March 2024.

Our Paper of the month for March is a retrospective longitudinal study emphasizing the important role of cortical myelin dynamics in determining neurodegeneration and clinical progression in MS.

Submit an essay on one of the two subjects below and you will have a chance to win a travel grant to the Congress, present your paper at the Scientific Theatre (on-site) and receive a certificate.

Following the election of the next EAN Board, we are asking for expressions of interest to join our committees and working groups.

The call is now open for the nomination of candidates for the EAN Board Election 2024.

The European Academy of Neurology has published a strategic neurological research agenda as a position paper in the European Journal of Neurology, to address current gaps and set priority areas for new clinically relevant research.

EAN President Paul Boon on the new all-time abstract submission record set for EAN 2024, and news of major recent and upcoming events.

Our paper of the month for February is an open-label extension study to assess the long-term efficacy and safety of cerliponase in padiatric patients with CLN2 disease.

Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2024.

Ahead of the International Day of Education on 24 January, Education Committee Chair, Irena Rektorova and eanCampus Editor-in-Chief, Barbara Tettenborn take a look at the EAN’s many activities in the field of education.